These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27383328)

  • 1. Clinical application of highly agglutinative staphylococcin in cancer treatment updates of the literature.
    Tian XL; Yan Z; Chen J; Zhao WH; Guo W
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2718-25. PubMed ID: 27383328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer.
    Guo N; Lin G; Shi X
    Pak J Med Sci; 2022; 38(7):1973-1979. PubMed ID: 36246715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional killing effect of staphylococcin 1580 and repair of sublethal injury in Staphylococcus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Antimicrob Agents Chemother; 1977 Sep; 12(3):314-21. PubMed ID: 20837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-mediated production of staphylococcin in bacteriophage type 71 Staphylococcus aureus.
    Dajani AS; Taube Z
    Antimicrob Agents Chemother; 1974 Jun; 5(6):594-8. PubMed ID: 15825411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy requirements for the action of staphylococcin 1580 in Staphyloccus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Biochim Biophys Acta; 1978 Mar; 539(3):372-85. PubMed ID: 204362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.
    Weerkamp A; Heinen-von Borries UT; Vogels GD
    Antonie Van Leeuwenhoek; 1978; 44(1):35-48. PubMed ID: 655698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic value of staphylococcin A in pyoderma].
    Wołowiec Z; Kindykiewicz L; Olszewski W
    Przegl Dermatol; 1978; 65(4):433-8. PubMed ID: 693931
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological conditions affecting Staphylococcus aureus susceptibility to staphylococcin 1580.
    Weerkamp A; Vogels GD
    Antimicrob Agents Chemother; 1978 Feb; 13(2):146-53. PubMed ID: 25615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
    O'Connor EB; Cotter PD; O'Connor P; O'Sullivan O; Tagg JR; Ross RP; Hill C
    BMC Microbiol; 2007 Apr; 7():24. PubMed ID: 17407564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance of bones and joints in animals to staphylococcin A and its administration in chronic osteomyelitis caused by staphylococcal infection].
    Radło W; Zarzycki D; Skolarczyk A; Iwaszczyszyn J
    Chir Narzadow Ruchu Ortop Pol; 1978; 43(2):139-42. PubMed ID: 668462
    [No Abstract]   [Full Text] [Related]  

  • 11. New possibilities of staphylococcin detection in the exfoliatin-producing strains of staphylococcus aureus.
    Skalka B; Pillich J; Pospísil L
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Mar; 254(1):34-41. PubMed ID: 6675344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity.
    Sahl HG; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):166-75. PubMed ID: 6181629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research on ultrasonically guided intrahepatic injections of HAS in interventional treatment of liver carcinomas.
    Mu P; Dong B; Liang P; Yu X; Su L; Zhang J
    J BUON; 2016; 21(6):1394-1397. PubMed ID: 28039698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria.
    Kader OA; Sahl HG; Brandis H
    J Gen Microbiol; 1984 Sep; 130(9):2291-300. PubMed ID: 6389764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5.
    Ersfeld-Dressen H; Sahl HG; Brandis H
    J Gen Microbiol; 1984 Nov; 130(11):3029-35. PubMed ID: 6527128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic activities of coagulase-positive staphylococci.
    Balusek J; Hájek V
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):147-54. PubMed ID: 4020118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional Catheterization Combined with Staphylococcin Aureus Injection in 112 Cases of Ischemic Necrosis of Femoral Heads.
    Liang J; Jiang X; Zhang X; Cao W; Wang Y; Han J
    Cell Biochem Biophys; 2015 Nov; 73(2):271-273. PubMed ID: 25733333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147.
    Draper LA; Grainger K; Deegan LH; Cotter PD; Hill C; Ross RP
    Mol Microbiol; 2009 Feb; 71(4):1043-54. PubMed ID: 19183281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.